Skip to content

Diurnal cortisol activity in methamphetamine addicts with and without adverse childhood experiences, a cross-sectional study

Diurnal cortisol activity in methamphetamine addicts with and without adverse childhood experiences, a cross-sectional study

Status
Active, not recruiting
Phases
Phase 1
Study type
Observational
Source
TCTR
Registry ID
TCTR20180910001
Enrollment
369
Registered
2018-09-10
Start date
2014-02-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

All stages of the study were conducted after obtaining informed consent and based on the latest version of Helsinki Declaration. Childhood adversity&#44

Interventions

Sponsors

none
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: The criteria for participating into the study were: (a) people aged between 18 to 35 years old (according to Allostatic load theory and the role of facing chronic stressors in the formation of an endocrine response, all participants in the study ranged from age 18 to 35 years); b) a history of at least two years of continuous consumption of methamphetamine with a inhalation pattern of about 0.5 to 1 grams per day; (c) detecting drug dependence based on DSM criteria; d) body mass index (BMI) between 18 to 35 kilograms (kg).

Exclusion criteria

Exclusion criteria: Exclusion criteria were also included of: (a) the diagnosis of any psychiatric disorder based on DSM-5, seizure, history of head trauma, endocrine disruption, cardiovascular disease or other specific chronic diseases; b) treatment in the last 6 months with antidepressants, neuroleptics, sedative, glucocorticoids, appetite suppressants, estrogens, dopamine medications; (c) experience of any stress currently and d) pregnancy, taking hormones or any stimulant or suppressive of cortisol medication. Money was paid to people for their participations.

Design outcomes

Primary

MeasureTime frame
cortisol level 4 weeks the enzyme-linked immunosorbent assay (ELISA)

Secondary

MeasureTime frame
Childhood Trauma 4 weeks Childhood Trauma Questionnaire

Countries

iran

Contacts

Public Contactbijan pirnia

Bijan Center

b.pirnia@usc.ac.ir+9802122081450

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026